Hussman Strategic Advisors, Inc. Neurocrine Biosciences Inc Transaction History

Hussman Strategic Advisors, Inc.

$320 Million
Q4 2024

A detailed history of Hussman Strategic Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 8,400 shares of NBIX stock, worth $1.03 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

8,400

Previous 31,500 73.33%

Holding current value

$1.03 Million

Previous $3.63 Million 68.39%

% of portfolio

0.36%

Previous 0.94%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$111.62 - $139.44 $2.58 Million - $3.22 Million	-23,100 Reduced 73.33%	8,400 $1.15 Million
Q3 2024 Nov 01, 2024	BUY	$114.58 - $153.15 $721,854 - $964,845	6,300 Added 25.0%	31,500 $3.63 Million
Q2 2024 Aug 01, 2024	BUY	$130.86 - $143.19 $1.92 Million - $2.1 Million	14,700 Added 140.0%	25,200 $3.47 Million
Q4 2023 Feb 01, 2024	SELL	$106.07 - $132.76 $1.9 Million - $2.38 Million	-17,900 Reduced 63.03%	10,500 $1.38 Million
Q3 2023 Nov 07, 2023	SELL	$94.02 - $117.1 $752,160 - $936,800	-8,000 Reduced 21.98%	28,400 $3.2 Million
Q2 2023 Aug 03, 2023	SELL	$89.53 - $104.87 $904,253 - $1.06 Million	-10,100 Reduced 21.72%	36,400 $3.43 Million
Q1 2023 May 04, 2023	BUY	$94.11 - $123.02 $1.93 Million - $2.52 Million	20,500 Added 78.85%	46,500 $4.71 Million
Q4 2022 Feb 08, 2023	SELL	$106.72 - $127.06 $554,944 - $660,712	-5,200 Reduced 16.67%	26,000 $3.11 Million
Q1 2022 May 04, 2022	BUY	$72.45 - $94.81 $1.51 Million - $1.97 Million	20,800 Added 200.0%	31,200 $2.93 Million
Q4 2021 Jan 31, 2022	SELL	$79.65 - $106.22 $406,215 - $541,722	-5,100 Reduced 32.9%	10,400 $886,000
Q2 2021 Aug 03, 2021	BUY	$89.43 - $102.27 $1.39 Million - $1.59 Million	15,500 New	15,500 $1.51 Million
Q4 2020 Feb 01, 2021	SELL	$86.91 - $108.33 $869,100 - $1.08 Million	-10,000 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$85.09 - $130.36 $425,450 - $651,800	-5,000 Reduced 33.33%	10,000 $1.22 Million
Q1 2020 May 01, 2020	BUY	$75.11 - $113.76 $1.13 Million - $1.71 Million	15,000 New	15,000 $1.3 Million
Q2 2019 Jul 31, 2019	SELL	$72.24 - $91.27 $722,400 - $912,700	-10,000 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$68.32 - $124.36 $683,199 - $1.24 Million	10,000 New	10,000 $714,000

Others Institutions Holding NBIX

# of Institutions

642

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account

Hussman Strategic Advisors, Inc. Neurocrine Biosciences Inc Transaction History